Related Experiment Video

Updated: Aug 23, 2026

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures
12:30

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures

Published on: July 2, 2014

Medial temporal lobe function and structure in mild cognitive impairment

Bradford C Dickerson1, David H Salat, Julianna F Bates

  • 1Department of Neurology, Gerontology Research Unit, Massachusetts General Hospital, MGH-East (149-2691), 149 13th Street, Charlestown, MA 02129, USA. bradd@nmr.mgh.harvard.edu

Annals of Neurology
|July 6, 2004
PubMed

Insights

In individuals with mild cognitive impairment (MCI), increased medial temporal lobe (MTL) activation during memory tasks may indicate compensatory mechanisms. This heightened activation could signal future cognitive decline and Alzheimer's disease (AD) pathology.

Area of Science:

  • Neuroimaging
  • Cognitive Neuroscience
  • Neurology

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Understanding the neural mechanisms underlying MCI is crucial for early detection and intervention.
  • Medial temporal lobe (MTL) structures are vital for memory function and are affected early in Alzheimer's disease (AD).

Purpose of the Study:

  • To investigate memory-associated activation in MTL regions in elderly individuals with MCI using functional magnetic resonance imaging (fMRI).
  • To explore the relationship between MTL activation patterns, memory performance, clinical status, and future cognitive decline.

Main Methods:

  • fMRI was employed to assess brain activation during a visual encoding task in 32 individuals with MCI.
  • Regions of interest (ROIs) within the MTL, including the hippocampal formation and parahippocampal gyrus (PHG), were identified.
  • Activation extent within ROIs was quantified and correlated with memory performance, clinical severity (Clinical Dementia Rating Sum of Boxes), and longitudinal follow-up data.

Main Results:

  • Greater activation in the hippocampal formation and PHG correlated with better memory performance.
  • A paradoxical finding emerged: individuals with greater clinical impairment and those who later declined showed increased right PHG activation during encoding.
  • This increased activation persisted even after controlling for brain atrophy.

Conclusions:

  • Increased MTL activation in MCI may represent a compensatory neural response to underlying AD pathology.
  • Heightened right PHG activation during memory encoding could serve as a potential biomarker for impending clinical decline in MCI.
  • Further research is warranted to elucidate the role of compensatory mechanisms in the progression of neurodegenerative diseases.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Related Concept Videos

Role of Hippocampus in Memory01:19

Role of Hippocampus in Memory

The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the cerebellum's...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...